267 results on '"Szamosi, Szilvia"'
Search Results
2. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases
3. Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases
4. Granulomatosis with polyangiitis or its mimic? A case report
5. Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology
6. A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis
7. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis
8. Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
9. Associations of vascular and bone status in arthritis patients
10. An in vivo confocal microscopy study of corneal changes in patients with systemic sclerosis
11. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
12. Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis
13. Monogénesen öröklődő és szerzett autoinflammatoricus betegségek.
14. Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
15. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis
16. Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis
17. Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis
18. Évaluation de l’immunogénicité du vaccin pneumococcique conjugué 13-valent chez des patients atteints de polyarthrite rhumatoïde traités par étanercept
19. Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept
20. Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients
21. Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis
22. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
23. A 18F-FDG-PET/CT helye az ismeretlen eredetű láz diagnosztikai algoritmusában
24. Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach
25. Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis
26. Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis
27. 07.02 Genetic signatures in rheumatoid arthritis: changes upon anti-tnf therapy and association with response to biological treatment
28. Malignancies associated with systemic sclerosis
29. Biologics — beyond the joints
30. Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients
31. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients
32. Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status
33. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
34. A 18F-FDG-PET/CT helye az ismeretlen eredetű láz diagnosztikai algoritmusában.
35. Pharmacogenetics and pharmacogenomics in rheumatology
36. Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology
37. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: Associations with organ manifestations, immunolaboratory markers and disease activity indices
38. Plasma Homocysteine Levels, The Prevalence of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Macrovascular Disorders in Systemic Sclerosis: Risk Factors for Accelerated Macrovascular Damage?
39. Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects
40. Additional file 2 of Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
41. Additional file 1 of Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
42. Additional file 3 of Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
43. Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis
44. Inorganic pyrophosphate is reduced in patients with systemic sclerosis
45. Gastrointestinal manifestations in Hungarian scleroderma patients
46. Long-term effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow-cytometry for more sensitive assessment of B cell depletion
47. Gyulladás és autoimmunitás Covid-19-ben
48. Combination of peripheral blood gene expression profiles and clinical parameters predicts response to tocilizumab treatment in rheumatoid arthritis
49. Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy
50. Onkoreumatológia: a daganatos és mozgásszervi kórképek összefüggései
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.